CAT
Caterpillar Inc.
CAT has the edge over PKOH overall, supported by stronger modeled upside and stronger fundamentals.
PKOH
Park-Ohio Holdings Corp.
PKOH offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
PKOH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
PKOH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over PKOH in the historical PE scenario, which offers more potential upside but is not a forecast.
PKOH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $19.71 | -58% |
| Forward | 13x | $46.92 | — |
| Fair | 19x | $45.91 | -2.2% |
| Current | 19x | $46.92 | — |
| Expensive | 28x | $68.52 | +46% |
Historical ranges are pointers, not guarantees.
PKOH's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over PKOH on the outlook, with more favorable profitability expectations.
PKOH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for PKOH, with profitability holding steady. However, they disagree widely on these estimates.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
PKOH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.68 | +50% |
| Q3 2026 | $2.45 | +49% |
| Q2 2026 | $1.87 | -6% |
| Q1 2026 | $1.67 | -26% |
| Q4 2025 | $1.70 | -29% |
| Q3 2025 | $1.64 | +32% |
| Q2 2025 | $1.99 | +43% |
| Q1 2025 | $2.25 | +150% |
| Q4 2024 | $2.40 | +287% |
PKOH has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over PKOH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over PKOH on profitability, with a higher operating margin.
PKOH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $458.5M | +15% |
| Q2 2026 | $440.1M | +10% |
| Q1 2026 | $421M | +3.8% |
| Q4 2025 | $395M | +1.7% |
| Q3 2025 | $398.6M | -4.5% |
| Q2 2025 | $400.1M | -7.5% |
| Q1 2025 | $405.4M | -2.9% |
| Q4 2024 | $388.4M | -0.2% |
PKOH's revenue has grown year over year for four quarters in a row: $459M last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +1.5 points |
| Q2 2026 | 5.6% | +0.6 points |
| Q1 2026 | 4.7% | 0 points |
| Q4 2025 | 2.5% | -1.2 points |
| Q3 2025 | 4.3% | -1.3 points |
| Q2 2025 | 5% | -0.7 points |
| Q1 2025 | 4.7% | -1.1 points |
| Q4 2024 | 3.7% | -0.8 points |
PKOH's operating margin was 5.8% last quarter, up 1.5 points from the same quarter a year ago, near the top of its range since 2019.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
PKOH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.1M | +7.6% |
| Q2 2026 | -$1.8M | +$19.3M |
| Q1 2026 | -$20.3M | -$800K |
| Q4 2025 | $36M | +108% |
| Q3 2025 | $6.6M | +$6.7M |
| Q2 2025 | -$21.1M | -$11M |
| Q1 2025 | -$19.5M | -$16M |
| Q4 2024 | $17.3M | -20% |
PKOH's free cash flow has turned positive after five years mostly in the red: $21M over the past year.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over PKOH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
PKOH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +100K shares |
| 1 year | +2.1% | +300K shares |
| 3 years | +13% | +1.7M shares |
| 5 years | +18% | +2.2M shares |
| Available history | +16% | +1.9M shares |
PKOH has 14M diluted shares, up 2.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q4 2021 | — |
| Q3 2021 | $2.5M |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $300,000 |
| Q3 2020 | $1.9M |
| Q2 2020 | $3.2M |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
PKOH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
PKOH has more cash than debt.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PKOH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 41.7 | Neutral |
PKOH's weekly RSI is 62 (neutral) and its Stochastic is 42 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
PKOH PE vs Industrials Sector
| Metric | PKOH | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 24x | 20% below |
| PE % | 51 | 58 | 7 pts below |
PKOH has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
PKOH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $45.8 | 2.4% above |
| 20 week MA | $44.4 | 5.7% above |
| 50 week MA | $33.8 | 39% above |
| 100 week MA | $27.3 | 72% above |
| 200 week MA | $25.0 | 88% above |
PKOH has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
PKOH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.3 | $30.2 | -9.5% |
| 2021 | $30.2 | $21.5 | -29% |
| 2022 | $21.5 | $12.0 | -44% |
| 2023 | $12.0 | $27.0 | +125% |
| 2024 | $27.0 | $25.8 | -4.2% |
| 2025 | $25.8 | $21.1 | -18% |
| 2026 YTD | $21.1 | $46.9 | +122% |
PKOH has the edge over CAT on returns for 2026, with the stronger performance.